Biotechnology, a key element on the program of the new PharmaProcess 2013 fair in Barcelona

By Biocat

The first edition of PharmaProcess (Innovation Forum in Pharmaceutical Process), on 29 and 30 October at Fira Barcelona, will bring together leaders and experts form the global pharmaceutical and biotechnology sectors with the aim of sharing knowledge and experience to innovate (organization and technology) in industrial drug production.

The Spanish pharmaceutical sector is concentrated mainly in Catalonia (46%), which is home to the headquarters of the leading companies. The PharmaProcess scientific committee is made up of companies like Almirall, Esteve, Grifols, Reig Jofré and Telstar and organizations like the European Federation of Pharmaceutical Industries and Associations (EFPIA), Farmaindustria, Biocat, International Society for Pharmaceutical Engineering (ISPE), and Spanish Generic Medicines Association (AESEG), among others.

The congress is broken down into three tracks: Development, Biopharmatech and Operations.

Biopharmatech track

Biotechnology is now contributing innovative solutions to develop more effective and specific drugs. Biocat is coordinating a track to debate the impact of biotechnology on the pharma industry, the latest breakthroughs in cell-culture technology to meet demand for biopharmaceutical products on a large scale, managing productive capabilities (combining internal capabilities with CMO services) and implanting single-use manufacturing models, nanotechnology for redesigning processes, the main regulatory problems of advanced therapies and biosimilars.

Participants:

• Jordi Martí, CEO of Cellgene (previously Amgen Spain)
• Montserrat Vendrell, CEO of Biocat (Catalonia)
• Pierre Monsan, Director of Toulouse White Biotechnology (France)   
• Josep Castells, Executive President of InKemia IUCT Group (Catalonia)
• Andy Racher, Head of Scientific Process Development at Lonza (United Kingdom)
• Alain Bernard, Vice-President, Biopharmaceutical Process Sciences at UCB Pharma (Belgium)  
• Francesc Godia, Professor of Chemical Engineering at the Autonomous University of Barcelona (Catalonia)
• Teresa Pellegrino, Researcher at the Italian Research Council’s National Nanotechnology Laboratory (Italy) 
• Víctor Puntes, ICREA Professor at the Catalan Institute of Nanotechnology (Catalonia)
• Xavier Llúria, Senior Consultant (United Kingdom)
• Joan Bigorra, Director of Innovation at Barcelona's Hospital Clínic
• Fernando de Mora, Professor of Pharmacology at the UAB (Catalonia)
• Adela Farré, Director of Communications and Institutional Relations of Biocat (Catalonia)

Information regarding the various participation options are explained on the website. Enter code JNY4Z8TB to get 25% off.

Date: 29 and 30 October 2013
Venue: Palau de Congressos de Barcelona • Av. Reina Maria Cristina, s/n (Montjuïc fairgrounds) • Barcelona (map)

Follow the forum on Twitter @Pharmaprocess with the hashtag #Pharmaprocess.

Questions:
Fira Barcelona
pharmaprocess.ventas@firabarcelona.com
Phone +34 93 233 20 00 / 902 233 200

Organized by:	Collaborators: